DTx Pharma Announces Appointment of Bryan Laffitte, Ph.D. as Vice President, Biology

2021-04-06T16:04:02-07:00July 28th, 2020|

DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced today the appointment of [...]